ARUP Consult Editorial Board

The six-member Editorial Board made up of University of Utah Department of Pathology faculty helps lead innovative and ongoing improvements to ARUP Consult. Members work with the ARUP Consult editorial team to establish development goals and set priorities, and to periodically review and update the Consult Editorial Policy.

Editorial Board members include (left to right) Reha Toydemir, Bo Hong, Brian Jackson, Kamisha Johnson-Davis and Eszter Lazar-Molnar.

Profile picture for Bo Hong

Bo Hong, MD

Assistant Professor of Pathology at the University of Utah School of Medicine
Medical Director of Cytogenetics and Microarray at ARUP Laboratories

Dr. Hong is an assistant professor of pathology at University of Utah School of Medicine. She received her MD from Beijing Medical University and completed a residency in internal medicine and hematology at People’s Hospital, Beijing Medical University. Dr. Hong completed a clinical cytogenetics fellowship at the University of Utah and is board certified by the American Board of Medical Genetics and Genomics. She is a fellow of the American College of Medical Genetics and Genomics.

Her academic interests include the clinical significance of cytogenetic findings in hematologic malignancies, particularly in pediatric leukemia.

Profile picture for Brian R. Jackson

Brian R. Jackson, MD, MS

Associate Professor of Pathology at the University of Utah School of Medicine
Medical Director of Business Development, Informatics, Support Services, and Referral Testing at ARUP Laboratories

Dr. Jackson directs the Informatics Department at ARUP, including ARUP Consult®, decision support, test utilization management, and software product management. He received his BA in mathematics, his MS in medical informatics, and his MD from the University of Utah, and completed a clinical pathology residency at Dartmouth-Hitchcock Medical Center. Before joining ARUP, Dr. Jackson was a staff clinical pathologist and informaticist at Dartmouth-Hitchcock Medical Center, a product manager for a Belgium-based medical software firm, and a National Library of Medicine informatics fellow at the University of Utah.

Dr. Jackson’s research interests include economic analysis of diagnostic testing and physician utilization of laboratory tests. He is certified in clinical pathology by the American Board of Pathology.

Profile picture for Kamisha Johnson-Davis

Kamisha Johnson-Davis, PhD, DABCC

Associate Professor of Pathology at the University of Utah School of Medicine Medical Director, Clinical Toxicology

Dr. Johnson-Davis received her BS in biochemistry from the University of California, Riverside, and her PhD in pharmacology from the University of Utah. She was a postdoctoral research associate at the Center for Human Toxicology and completed a postdoctoral fellowship in clinical chemistry at the University of Utah Department of Pathology. Dr. Johnson-Davis is board certified in clinical chemistry and toxicological chemistry. She is a diplomate of the American Board of Clinical Chemistry and a fellow of the National Association of Clinical Biochemistry and the Association of Clinical Scientists.

Profile picture for Jordon K. March, MD

Jordon K. March, MD

Anatomic and Clinical Pathology Resident at the University of Utah School of Medicine/ARUP Laboratories
Associate Medical Director, ARUP Consult, ARUP

Dr. March received his bachelor’s degree in microbiology and bacteriology from Brigham Young University, where he developed polymerase chain reaction-based and gas chromatography-mass spectrometry-based assays for the rapid identification and differentiation of numerous CDC select agents.

He received his MD degree from the University of Nevada, Reno School of Medicine. While in medical school, he studied various modalities for the detection and diagnosis of melanoma.

Dr. March’s academic interests include medical education optimization and digital pathology utilization.

Profile picture for Eszter Lazar-Molnar

Eszter Lazar-Molnar, PhD, D(ABMLI)

Assistant Professor of Pathology at the University of Utah School of Medicine
Assistant Director of the Histocompatibility and Immunogenetics Laboratory at University of Utah Healthcare
Medical Director of Immunology at ARUP Laboratories

Dr. Lazar-Molnar received her PhD in biological sciences at the Semmelweis University in Budapest, Hungary. She completed a postdoctoral fellowship in the laboratory of Dr. Stanley G. Nathenson at the Albert Einstein College of Medicine in New York, where she studied immune regulation through co-stimulatory molecules and finding new ways for designing immunotherapy. She received a Cancer Research Institute postdoctoral fellowship and the Belfer Outstanding Postdoctoral Research Award in 2009. She also completed a clinical immunology fellowship at the University of Utah. Dr. Lazar-Molnar is board certified by the American Board of Medical Laboratory Immunology.

Dr. Lazar-Molnar has been the recipient of several honors and awards, most recently the Clinical Immunology Society Travel Award to the 2015 Primary Immunodeficiency Diseases Summer School.

Her research interests include cellular immunology, immunotherapy, and transplantation immunology.

Profile picture for Reha M. Toydemir

Reha M. Toydemir, MD, PhD, FACMG

Assistant Professor of Pathology and Adjunct Assistant Professor of Pediatrics at the University of Utah School of Medicine
Director of the Clinical Cytogenetics Fellowship at the U of U School of Medicine
Medical Director of Cytogenetics and Genomic Microarray at ARUP Laboratories

Dr. Toydemir was the recipient of the 2007 James W. Prahl Award for Outstanding Contributions by a Graduate Student in the biological or biomedical science at the University of Utah, and is a member of the American Society of Human Genetics and Turkish Society of Medical Genetics.

Dr. Toydemir’s research interests focus on understanding the genetic basis of congenital musculoskeletal abnormalities, especially those affecting the distal joints. He also conducts research on nonsyndromic developmental dysplasia of the hip, utilizing classical mapping methods as well as next generation sequencing technology. Other interests include implementation of advanced genetic technologies in detection and characterization of chromosome aberrations in hematological malignancies.

Last Update: November 2018